explore -WSS

explore

author：explore 2025-10-02 11:08:20 - browse：489

Priscilla Chan, left, with Shana Kelley and Gov. J.B. Pritzker of Illinois at the new CZ Biohub Chicago. Courtesy Dale Ramos/Chan Zuckerberg Initiative

CHICAGO — At what point does inflammation, a key component of the body’s immune defense system, swerve out of control and start to drive disease?

That’s the key question that a new research center, the Chan Zuckerberg Biohub Chicago, has been created to try to answer.

The Chicago hub is the second one started by the Chan Zuckerberg Initiative, the philanthropic organization of Facebook founder Mark Zuckerberg and his wife, Priscilla Chan. The first hub, based in the Bay Area, has been investigating cell biology and infectious diseases, while this new one is homing in on inflammatory processes in tissues across the body.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Caribou posts encouraging results on off

WSS

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Long Covid research funding gets a major boost from NIH

The stock market has soared this year, but will it last? Experts weigh in

Study gives hint on South Asians’ higher risk of cardiovascular disease

Websites selling Wegovy, Zepbound ingredients targeted by FDA

5 dead in mass shooting on Caribbean island of St. Vincent: Police

focus

explore

focus

ChatGPT in medicine: STAT answers readers' burning questions

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Guidelines to prevent youth baseball injuries need more muscle

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Sports medicine is finally prioritizing gender equality

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Anesthesiologist group: stop taking Ozempic before surgery

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Bright Health sells Medicare Advantage business to Molina

Stanford president’s abrupt resignation sparks debate

explore

AMAs digital advisors table RPM coding reform proposal, again

Report cites 'urgent' need to recruit more diverse clinical trial participants

Dementia risk linked to living in disadvantaged areas: Study

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

focus

hotspot

entertainment

leisure time